TransAlta Corporation offers an enticing investment prospect amid the North American energy transformation. With a diversified generation portfolio and a focus on renewables, TransAlta is well-positioned for growth, despite Alberta's...
Key Takeaways Evolution AB’s operating margin declined to 58% in Q2 2025, a 3-percentage-point drop from 61% in the prior year, signalling increased pressure on profitability. Despite the margin compression,...
Key Takeaways American Express surpassed Q2 2025 forecasts, delivering an EPS of $4.08 against an expected $3.86 and revenue of $17.9 billion against a $17.7 billion consensus. Revenue increased by...
Life360, a key player in the family safety sector, presents a fascinating investment opportunity. Its robust subscription model and strategic market expansion support a Buy recommendation with a 12-month price...
Merus N.V. emerges as a standout in the immuno-oncology arena, leveraging its proprietary Biclonics® platform to develop bispecific antibodies aimed at targeted cancer therapies. With a robust financial footing, promising...
Key Takeaways Rocket Lab’s strategy of vertical integration—controlling design, manufacturing, and mission management—provides a significant competitive advantage in the space industry by enhancing speed and cost efficiency. This integrated model...
Key Takeaways Lemonade leverages AI to streamline insurance operations, but faces significant profitability challenges, highlighted by a high combined ratio of 204% in Q1 2025. Despite strong year-over-year revenue growth...
Rambus Inc. thrives in the high-bandwidth memory semiconductor sector, offering a strategic investment opportunity fueled by DDR5 adoption and AI infrastructure demands. Dominating the server DDR5 RCD market with over...
Key Takeaways A forced change in Federal Reserve leadership could severely undermine market confidence, potentially destabilising the US dollar and triggering a sell-off in the US bond market. The US...
Key Takeaways A significant year-to-date decline in UnitedHealth Group’s stock in 2025 has created a potential valuation mismatch, with its forward P/E ratio falling to between 12 and 13. The...
